Imagen del editor
Hardcover. This volume gives an overview ofstate of the art technologies and future developments in the field ofpreclinical pharmaceutical research. A balanced mix of experts from academ.Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. 341 pages. 0.726. N° de ref. de la librería 9783319289120
This volume gives an overview of state of the art technologies and future developments in the field of preclinical pharmaceutical research. A balanced mix of experts from academia and industry give insight in selected new developments in the drug discovery pathway. The topics cover the different parts of the drug discovery process, starting with new developments in the target identification and validation area. The lead generation part as a next step focuses on the requirements and technologies to identify new small molecules as lead compounds for further optimization; in a second section the technologies to identify biologics as leads are addressed. The final part focuses on the pharmacological models and technologies to characterize new compounds and the impact of biomarkers to facilitate the transfer of drug candidates into the development phase.
About the Author: Dr. Ulrich Nielsch, Bayer Pharma AG,Wuppertal, GermanyDr. Ulrike Fuhrmann, Bayer Pharma AG, Berlin, GermanyProf. Dr. Stefan Jaroch, Bayer Pharma AG, Berlin, Germany
Título: New Approaches to Drug Discovery (Hardcover)
Año de publicación: 2016
Condición del libro: New
Descripción Springer, 2016. Estado de conservación: New. Nº de ref. de la librería L9783319289120